Dr. Debasish Biswal is a medical microbiologist with a strong research portfolio focused on antimicrobial resistance, molecular diagnostics, infection prevention, and intensive-care–associated infections. His scholarly output comprises 26 peer-reviewed research documents, collectively accruing 45 citations with an h-index of 4, reflecting sustained impact across clinical and translational microbiology. His work spans carbapenemase detection, synergy testing of novel β-lactam/β-lactamase inhibitor combinations, rapid molecular diagnostics for bacterial meningitis and tuberculosis, and genomic epidemiology of multidrug-resistant pathogens. He has contributed to high-impact journals in medical microbiology, critical care, infectious diseases, and parasitology, often integrating laboratory diagnostics with clinical outcomes and infection control strategies. Ongoing research includes evaluation of next-generation antimicrobial combinations against extensively drug-resistant organisms and assessment of advanced molecular platforms for extrapulmonary tuberculosis. His research emphasizes evidence-based antimicrobial stewardship, surveillance of healthcare-associated infections, and translational diagnostics to inform policy and clinical practice.